Metabolic SyndromeNCT03009279
Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)
An observational study of Metabolic Syndrome and Thyroid Nodule, run by Lin Liao.
Trial summary
To investigate the association between metabolic syndrome (MS) and thyroid nodule(s). Read more about this study
- Who is it for?
- Ages 15 to 90 yearsHealthy volunteers can take part
- Conditions the study is for
- Metabolic Syndrome, Thyroid Nodule
- How many people
- 10,000 participants
- Where
- No sites listed yet
- Study dates
- Jan 2017to Dec 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 90 years
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: People who received routain physical and laboratory examinations in the Health Management Cenre of QianFoShan Hospital from Jan. 2013 to Dec. 2015.
Who may be able to join
- People who received routain physical and laboratory examinations in the Health Management Cenre of QianFoShan Hospital from Jan. 2013 to Dec. 2015.
- signed the informed consent.
- Have complete clinical data.
Who cannot join
- Patients with previous history of thyroid disease other than thyroid nodules.
- People with abnormal thyroid function.
- Thyroid ultrasound revealed patients with other lesions other than normal thyroid and thyroid nodules.
- Pregnant or lactating women.
Trial locations and contacts
No sites are listed yet.
About this study
To investigate the association between metabolic syndrome (MS) and thyroid nodule(s).
Read the detailed description
To investigate the association between metabolic syndrome (MS), body mass index (BMI), hyperglycemia, dyslipidemia, hypertension and thyroid nodule(s) or thyroid functions in euthyroid subjects. Screen for the risk factors that affect the incidence of thyroid nodule(s).
- Conditions
- Metabolic Syndrome, Thyroid Nodule
- Keywords
- blood pressure, fasting plasma glucose, thyroid stimulating hormone
- Medical subject headings
- Metabolic Syndrome, Thyroid Nodule
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| The MS group | Patients with metabolic syndrome(MS). | |
| The non-MS group | Patients without metabolic syndrome(MS). |
What is being measured
The primary outcome is the main question the study is designed to answer.
The laboratory examinations
Lipids,glucose,thyroid functions
Measured: In 2013-2015
Secondary outcomes (1)
Blood pressure of patients in each group
Measured: In 2013-2015
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Jan 2017 (estimated)
- Study startJan 2017
- Primary completionNov 2017 (estimated)
- Study completionDec 2017 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Metabolic SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Enrolment
- 10,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Lin Liao
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Lin Liao, Qianfoshan Hospital
- Investigators
- Lin Liao, Study chair, Qianfoshan Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03009279
- Sponsor's protocol ID
- qfsnfm-004
- Status last verified
- Jan 2017
- First submitted
- 26 Dec 2016
- Last updated
- 9 Jan 2017
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 9 Jan 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)
- ClinicalTrials.gov ID
- NCT03009279
- Acronym / sponsor ID
- qfsnfm-004
- Conditions
- Metabolic Syndrome, Thyroid Nodule
- Keywords
- blood pressure, fasting plasma glucose, thyroid stimulating hormone
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 10,000 participants (estimated)
- Lead sponsor
- Lin LiaoUniversity, hospital or other
- Study start
- Jan 2017
- Primary completion
- Nov 2017 (estimated)
- Study completion
- Dec 2017 (estimated)
- First posted
- 4 Jan 2017 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To investigate the association between metabolic syndrome (MS) and thyroid nodule(s).
Detailed description
To investigate the association between metabolic syndrome (MS), body mass index (BMI), hyperglycemia, dyslipidemia, hypertension and thyroid nodule(s) or thyroid functions in euthyroid subjects. Screen for the risk factors that affect the incidence of thyroid nodule(s).
Study design
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| The MS group | – | –Patients with metabolic syndrome(MS). |
| The non-MS group | – | –Patients without metabolic syndrome(MS). |
Who may qualify
- Ages
- 15 to 90 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- People who received routain physical and laboratory examinations in the Health Management Cenre of QianFoShan Hospital from Jan. 2013 to Dec. 2015.
Key inclusion criteria (3 listed)
- People who received routain physical and laboratory examinations in the Health Management Cenre of QianFoShan Hospital from Jan. 2013 to Dec. 2015.
- signed the informed consent.
- Have complete clinical data.
Key exclusion criteria (4 listed)
- Patients with previous history of thyroid disease other than thyroid nodules.
- People with abnormal thyroid function.
- Thyroid ultrasound revealed patients with other lesions other than normal thyroid and thyroid nodules.
- Pregnant or lactating women.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
The laboratory examinations
Time frame: In 2013-2015
Lipids,glucose,thyroid functions
1 secondary outcome
Blood pressure of patients in each group
Time frame: In 2013-2015
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jan 2017.
- Individual participant dataSharing planned: Yes
Related trials for Metabolic Syndrome
RecruitingObservational study
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Fanconi Anemia, Inherited Bone Marrow Failure Syndrome
Not yet recruitingPhase 2
Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2)
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Not yet recruitingPhase 2
Effects of Meal Macronutrients on Postprandial Lipids
Nephrotic Syndrome, Lipodystrophy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lin Liao study chair
Qianfoshan Hospital
Questions about this trial
What is this clinical trial studying?
An observational study of Metabolic Syndrome and Thyroid Nodule, run by Lin Liao.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Lin Liao, MD (8615168888260, liaolin@medmail.com.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The laboratory examinations (time frame: In 2013-2015). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2017.